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Abstract 
 
The hexasaccharide β-D-Galp-(1→2)-[β-D-Galp-(1→3)]-β-D-Galp-(1→6)-[β-D-Galp(1→2)-β-
D-Galf(1→4)]-D-GlcNAc (10) and its β-D-Galf-(1→2)-β-D-Galf containing isomer (7) are the 
largest carbohydrates in mucins of some strains of T. cruzi. The terminal β-D-Galp units are sites 
of sialylation by the parasite trans-sialidase. Hexasaccharide 10 was chemically synthesized for 
the first time by a [3+3] nitrilium based convergent approach, using the trichloroacetimidate 
method of glycosylation. The 1H NMR spectrum of its alditol was identical to the spectrum of the 
product released by β-elimination from the parasite mucin. The trans-sialylation reaction studied 
on the benzyl glycoside of 10 showed two monosialylated products whose relative abundance 
changed with time. On the other hand, only one product was produced by sialylation of the benzyl 
glycoside of 7. A preparative synthesis of the latter and spectroscopic analysis of the product 
unequivocally established the sialylation site at the less hindered (1→3)-linked galactopyranose. 
 
Keywords: Trypanosoma cruzi; mucins; trans-sialidase; glycosylation; galactofuranose; nitrilium; 
oligosaccharides.  
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1. Introduction 
Trypanosoma cruzi, the etiologic agent of Chagas disease, differentiates during its life cycle 
as it travels from the insect vector to humans, undergoing biochemical and morphological 
changes.1,2 Epimastigotes replicate in the midgut of a triatomine insect and transform in the 
intestine into non-proliferative metacyclic trypomastigotes that pass from the hindgut to the feces. 
The infective trypomastigotes enter the vertebrate host through a skin wound or mucosal 
membranes, invade cells and differentiate into amastigotes which, after several cycles of binary 
division, differentiate back into trypomastigotes. These non-replicative forms are released into 
circulation upon host-cell rupture and may then infect other cells or be taken by the insect vector 
on blood sucking. The ingested trypomastigotes transform into epimastigotes, closing the cycle. A 
dense glycocalix covers the surface of the parasite and its composition is characteristic of each 
differentiation stage.3,4 Mucins are the most abundant of the surface glycoproteins and both, 
epimastigote and infective trypomastigote forms, have the same number of mucin molecules per 
surface area.5 Their O-linked oligosaccharides, which account for up to 60% of the molecular 
mass, play the crucial role of being acceptors of the sialic acid that the parasite needs to build a 
negatively charged coat but is unable to biosynthesize. For the acquisition of sialic acid, T. cruzi 
expresses at its surface a trans-sialidase (TcTS), capable of transferring sialic acid residues from 
host glycoconjugates to the parasite mucins.6-8 The transfer is specific and involves cleavage of an 
α(2→3)-linked sialic acid in the donor and formation of the same linkage with a terminal β-
galactopyranosyl group in the acceptor substrate. The acceptor binding-site was studied with 
modified substrates and glycoside libraries showing the importance of substitution at the different 
galactose positions.9 Galactose is a constituent of all mucin oligosaccharides, however, in 
epimastigotes, the monosaccharide may be present in the furanose and pyranose configurations. 
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By comparing structural data of mucins from different strains it follows that the O-linked 
oligosaccharides may be derived from two cores, β-D-Galp(1→4)-GlcNAc or β-D-Galf(1→4)-
GlcNAc. These cores are further branched with various units of Galf and/or Galp. Galactofuranose 
was first reported in mucins of a sylvatic origin like the G strain, classified as T. cruzi I,10,11 and 
found later in other strains belonging to the same group.12 More recently, it was reported in the 
drug-resistant Colombiana strain, isolated from a chronic human case in Colombia.13 The 
Tulahuen strain, now included in the new hybrid type VI14 expresses mucins with substitution of 
GlcNAc by either Galp or Galf.15 By a comparative kinetic study it was shown that the presence of 
Galf does not interfere with the acceptance of sialic acid by the Galp in the oligosaccharides.16 The 
diminished virulence of the strains belonging to group I could be caused by the antigenicity of 
Galf.17 On the other hand, galactose only in the pyranose form was found in mucin 
oligosaccharides belonging to other strains18-21 and some of these structures have been 
synthesized.22 
In our laboratory we have undertaken the chemical synthesis of the mucin oligosaccharides, 
in particular of those containing Galf (Figure 1).23-27 Reduction with NaBH4 gave the 
corresponding alditols that allowed the comparison with the oligosaccharide alditols obtained by 
reductive β-elimination from the natural mucins, confirming the proposed structures.  
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Figure 1. Structures of Galf-containing mucin oligosaccharides from T. cruzi epimastigotes. 
 
Hexasaccharides 7 and 10 (Figure 2) are the largest oligosaccharides obtained as alditols in 
T. cruzi epimastigote mucins by reductive β-elimination. 10-13,15 These isomeric structures differ in 
the galactose unit linked to the O-2 of the internal galactofuranose in the conserved β-D-
Galf(1→4)GlcNAc core. The external Galf of the β-D-Galf(1→2)-β-D-Galf(1→4) unit present in 7 
is replaced by a Galp in 10. We have recently reported the synthesis of the hexasaccharide 7.28 We 
describe now the synthesis of β-D-Galp(1→2)-[β-D-Galp(1→3)]-β-D-Galp(1→6)[β-D-
Galp(1→2)-β-D-Galf(1→4)]-D-GlcNAc (10) and the corresponding benzyl glycoside 11 and 
alditol 12 (Figure 2).  
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9, Galp(β1→2)[Galp(β1→3)]Galp(β1→6)[Galf(β1→2)Galf(β1→4)]GlcNAcol 
12, Galp(β1→2)[Galp(β1→3)]Galp(β1→6)[Galp(β1→2)Galf(β1→4)]GlcNAcol 
Figure 2. Structures of the largest oligosaccharides found in T. cruzi epimastigote mucins 
 
The benzyl hexasaccharide derivatives 8 and 11, and their corresponding alditols 9 and 12 
were analyzed as acceptors in the trans-sialidase reaction catalyzed by a recombinant TcTS in 
order to establish potential differences in specificity. Whereas already synthesized 
Galf(1→2)containing hexasaccharide 7 presents two terminal Galp residues, hexasaccharide 10 
presents an extra terminal β-D-Galp residue for possible sialylation. Kinetic studies were 
performed in order to determine the specificity and degree of sialylation.  
 
2. Results and Discussion 
2.1.  Synthesis of hexasaccharide 10 
Retrosynthetic analysis for hexasaccharide 10 indicated a [3+3] nitrilium based 
glycosylation between already synthesized Galp-containing trisaccharide imidate 1326 and the 
trisaccharide acceptor 1427 which contains an internal Galf (Scheme 1). The trichloroacetimidate 
method with acetonitrile as solvent, was used for selective β-glycosylation.29,30 Due to the nitrile 
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effect31-35 only the desired β-isomer was obtained, despite the absence of anchimeric participation 
in the donor 13. The protected hexasaccharide 15 was obtained in 33% yield and unreacted 
acceptor 14 was also recovered. Interestingly, in the preparation of the Galf(1→2)Galf 
hexasaccharide 7, similar reaction conditions gave higher yields (56 %).28 When the terminal tetra-
O-benzoyl-Galf was replaced by a tetra-O-acetyl-Galp in the trisaccharide acceptor 14, the 
glycosylation yield diminished but the β-stereochemistry was maintained.  
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Scheme 1. Synthesis of hexasaccharide 10 and its benzyl glycoside 11 and alditol 12 
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The 1H and 13C NMR spectra assignments for 15 were performed on the basis of the COSY 
and HSQC experiments. In the 13C NMR spectrum, the signals corresponding to the six anomeric 
carbons could be easily identified. Thus, the signal for the new β-D-Galp(1→6) linkage appeared 
at δ 102.3 ppm, more deshielded than the ones for the anomeric carbons of the three terminal β-D-
Galp (δ 100.0, 99.9 and 99.3 ppm). The furanosic anomeric carbon in β-configuration appeared 
even more deshielded (δ 105.9 ppm), as expected. Comparing with the 13C NMR spectrum of the 
peracetylated benzyl glycoside of the related pentasaccharide 6,26 substitution at C-2 of the Galf 
caused a 1.2 ppm shift to a higher field. On the other hand, C-1 of α-GlcNAc was shown at δ 96.1 
ppm, as expected. The anomeric β-configuration of the new glycosidic linkage was confirmed by 
the coupling constant of J1,2 7.6 Hz for the Galp(1→6) H-1 signal at δ 4.66 in the 1H NMR 
spectrum. This signal correlated (HSQC) with C-1 at 102.3 ppm. The next step was the 
deacylation of 15 with sodium methoxide to give benzyl glycoside 11 in 98 % yield. 13C and 1H 
NMR spectra assignments for 11 were performed based on HSQC, COSY and ROESY 
experiments and by comparison with the shifts for the benzyl hexasaccharide 8 and the related 
benzyl glycoside of pentasaccharide 6. In the anomeric region of the 13C NMR spectrum of 11, the 
most deshielded carbon at δ 107.5 corresponded to C-1B of the β-Galf, whereas at δ 96. 6 appeared 
de C-1A of GlcNAc. The C-1 of the four Galp units appeared at δ 104.7 (C-1F Galp(1→3)), 103.4 
(C-1E Galp(1→2)Galp), 102.4 and 102.3 (C-1D Galp(1→6) and C-1C Galp(1→2)-Galf). In the 1H-
NMR spectrum four β-Galp anomeric carbons were identified by their typical J values (7-8 ppm) 
and unambiguously assigned by bi-dimensional spectroscopy. Two doublets at δ 5.54 (J1,2 = 2Hz) 
and δ 4.96 (J1,2 = 3.5Hz) were assigned to the β-Galf and α-GlcNAc respectively. Each terminal 
Galp unit could be assigned based on the ROESY experiment. The signal of H-1C of the 
Galp(β1→2)linked to Galf at δ 4.60 correlated with H-2B (δ 4.38) of the Galf unit. The H-1E of the 
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Galp(β1→2) linked to Galp at δ 4.83 showed a key correlation with H-2D of internal Galp (δ 
3.96), whereas the H-1F of the Galpβ(1→3) (δ 4.67) correlated with H-3D of the internal Galp D (δ 
4.02). 
The free hexasaccharide 10 was obtained in 94% yield by hydrogenolysis of 11 with H2 and 
Pd(C). The NMR spectra indicated that 10 was an anomeric mixture with a preponderance of the 
α-anomer. In the 13C-NMR spectrum of 10 the signals for β and α GlcNAc appeared at δ 95.9 and 
91.4 ppm respectively. 
Reduction of 10 with NaBH4 gave alditol 12 (82%). Comparison of its 1H and 13C NMR 
spectra confirm the structures proposed for the hexasaccharide alditol obtained by reductive β-
elimination of T. cruzi mucins.10,11 
 
2.2. Kinetic properties of the hexasaccharides in the TcTS reaction 
Compounds 11 and 12 present three terminal β-Galp units for possible sialylation by TcTS 
whereas in the benzyl glycoside 8 and alditol 9 of the isomeric hexasaccharide 728 one of the 
terminal Galp is replaced by a Galf and, consequently, have one less site for sialylation. The four 
hexasaccharide derivatives 8, 9, 11 and 12 were assayed as acceptor substrates for TcTS using 
conditions previously described for incubation with the donor 3´siallyllactose (SL).26 The progress 
of sialic acid transfer was followed by HPAEC-PAD under three different conditions (see 
Experimental).  
Incubation with TcTS and SL of benzyl glycoside 8, containing two external Galp units, 
showed only one sialylated species, S-8 (Table 1). This behaviour was in agreement with previous 
results obtained for the benzyl glycoside of pentasaccharide 626 and for benzyl 2,3-di-O-(β-D-
Galp)-β-D-Galp.36  Monosialylation ocurred only at the less hindered (1→3) linked Galp unit with 
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no evidence of disialylated products.26,36 2,3-di-O-(β-D-Galp)-β-D-Galp is the terminal constituent 
of both hexasaccharides and pentasaccharide 6 (Figure 1 and 2). On the other hand, benzyl 
glycoside 11, with three terminal Galp showed two monosialylated compounds, S-11a and S-11b, 
and a trace of another compound, S2-11, that would correspond to a disialylated derivative (Table 
1). Besides, the replacement of an external Galp by a Galf caused a significant increase in the 
retention times as previously observed for other Galf-containing oligosaccharides16,37 (Table 1). 
The same experiment performed on the alditols gave similar results. Galf(1→2)Galf-containing 
compound 9 produced only one sialylated species S-9, whereas two monosialylated compounds 
(S-12a and S-12b) and traces of a disialylated product (S2-12) were observed in the case of 12. 
Accordingly, radiolabeled mono and disialylated species have been detected by trans-sialylation 
of alditols released by reductive β-elimination from epimastigote and metacyclic trypomastigote 
mucins (G strain).10 
 
Table 1. KM and retention times of compounds 8, 9, 11 and 12 and their sialylated derivatives.  
+ 
Compd Retention time* Sialylated Compound 
Retention time* KM (mM) Cond. 1 Cond. 2 Cond. 3 Cond. 1 Cond. 2 Cond. 3 
8 0.23 0.75 0.70 S-8 2.73 1.33 1.45 0.12 ± 0.01 
9 0.52 0.81 0.70 S-9 2.91 1.31 1.13 0.32 ± 0.21 
11 0.18 0.38 0.28 S-11a 
S-11b 
S2-11 
0.68  
0.74  
2.02 
0.89  
0.91  
1.49 
0.80  
0.85 
1.59 
0.40 ± 0.01 
12 0.19 0.38 0.30 S-12a 
S-12b 
S2-12 
0.71  
0.78  
1.89 
0.94 
0.96 
1.49 
0.81  
0.85 
1.54 
0.46 ± 0.06 
*Relative to SL retention time (7.8-8.3 min for Condition 1; 13.6-14.3 min for Condition 2 and 12-12.5 min 
for Condition 3).  
 
 
The apparent KM values for each acceptor were estimated in order to quantify their relative 
affinity to the enzyme (Table 1). The values obtained were similar, supporting previous results 
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showing that the presence of a Galf residue in the acceptor substrate does not interfere with the 
sialylation reaction.16 
Hexasaccharide 10 may be formally seen as the combination of two trisaccharides: 2,3-di-O-
(β-D-Galp)-β-D-Galp and Galp(β1→2)Galf(β1→4)GlcNAc (2), both good acceptors of sialic 
acid.16 Thus, we could foreseen the formation of two monosialylated products, resulting from 
sialylation of either of the Galp acceptor residues of the constituent trisaccharides (Scheme 2).  
 
Scheme 2. Sialylation of compound 11 by TcTS. 
 
In order to investigate the kinetic of the sialylation, the reaction was studied for the benzyl 
glycoside 11 using different ratios of the donor SL to the acceptor and different times of 
incubation. With a 1:1 ratio of SL to 11 and after 15 min incubation with TcTS one main 
monosialylated product (Rt 10.1 min, S-11a) was detected (data not shown). Increasing the amount 
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of SL (2:1 ratio) resulted in the appearance of the expected S-11a and two minor peaks of Rt 10.6 
and 20.1 min that would correspond to the other monosialylated (S-11b) and the disialylated 
compound (S2-11), respectively (Figure 3). Increasing the incubation times from 15 to 120 min 
resulted in an inversion of the proportions of the monosialylated derivatives (S-11a and S-11b) 
with no increase in the amount of disialylated compound (S2-11). At the same time a higher 
consumption of SL and production of sialic acid was observed. Based on our previous results26,36 
and the studies described below on trans-sialylation of 8, we assume that only the external β-
Galp(1→3) and β-Galp(1→2)Galf linked units could be sialylated (Scheme 2). However, we 
cannot predict, at the present time, which of the two Galp residues is sialylated first or, if S-11b is 
formed at the expense of S-11a acting as sialic acid donor. The same experiment performed on 
alditol 12 showed that the relative proportions of the monosialylated derivatives did not change 
with time (data not shown). Introduction of a second sialic acid in the same molecule by TcTS is 
not as favorable as monosialylation. 
 
2.3. Selective sialylation of hexasaccharide 8  
With the aim of confirming the only site of sialylation in hexasaccharide 8, a preparative 
sialylation reaction was performed (Scheme 3). 
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Scheme 3. Site of sialylation of hexasaccharide 8 by TcTS 
 
The α-benzyl glycoside 8 was selected because the hydrophobic aglycon allowed an easier 
isolation by anion exchange chromatography of the sialylated derivatives from the remaining 
sialyllactose used as donor. On the other hand, the natural hexasaccharide is α-linked to threonine 
or serine in the mucins. The reaction was monitored by HPAEC and no evidence of the presence 
of another monosialylate or disialylated compound was observed (Figure 4). The reaction product 
was purified using an AG1X2 (acetate form) resin column. After elution of neutral sugars with 
water, the acidic components were eluted with 200 mM pyridinium acetate buffer, pH 5.0. The 
sialyl derivative S-8 was characterized on the basis of NMR spectroscopy.  
 
2.3.1. Characterization of S-8 
The expected molecular mass of the trans-sialylation product was confirmed by ESI -TOF 
positive mass spectrometry. The peak at 1435.4804 was assigned to [M+Na]+. Peaks 
corresponding to [M+Na-Gal]+, [M-Gal-OBn]+ and [M+Na-Gal-sialic acid]+ were observed at 
1273.4354, 1144.3876 and 982.3339, respectively. In the 1H NMR spectrum of the sialylated 
oligosaccharide, the presence of the diagnostic signals for the sialyl residue corresponding to the 
deoxy group were observed at δ 1.81 ppm (H-3a) and δ 2.76 ppm (H-3e) (Figure 5). Integration of 
these signals confirmed that only one sialic acid unit has been introduced. A new singlet 
corresponding to the NAc group of neuraminic acid appeared at δ 2.03 ppm.  
The six anomeric protons were distinctly shown with the two β-Galf appearing as singlets at 
δ 5.47 and 5.24 ppm. The shifts were compared with those for the hexasaccharide substrate 8.28 As 
a consequence of sialylation the signal for the anomeric proton of the β-Galp(1→3) was shifted to 
  
14 
 
lower fields (δ 4.71ppm) with respect to the signal in the original hexasaccharide (δ 4.66 ppm). 
Two dimensional NMR experiments (COSY, TOCSY, HSQC and NOESY) allowed the 
unequivocal determination of the site of sialylation. The characteristic doublet of doublets of H-3F 
signal of the sialylated Galp was shifted from δ 3.68-3.59 in 8 to δ 4.09 ppm in S-8 (J2,3 = 8 Hz 
and J3,4 = 3.4 Hz). The signal for the H-2F (TOCSY spectrum) that correlates with H-3F was also 
shifted downfield (δ 3.64 ppm) and correlated with H-1F at δ 4.71 ppm assigned to the Galp-
β(1→3) linked unit (F). The H-2D signal (δ 3.85) of the internal Galp (unit D) was determined by 
a correlation with H-1D (δ 4.54 ) in the COSY experiment. As NOESY correlation between H-3D 
and H-1F was overlapped by the HDO signal, we looked for the NOESY correlation between H-2D 
and H-1E which indicated that Galp(1→2) (unit E) was not sialylated. In this way, we confirmed 
that the Galp-β(1→3) unit (F) was sialylated as in the case of benzyl 2,3-di-O-(β-D-Galp)-β-D-
Galp36 and the benzyl glycoside of pentasaccharide 6.26 
 
3. Conclusion 
The β-D-Galp-(1-2)-β-D-Galf containing hexasaccharide 10 was chemically synthesized for 
the first time, by a convergent approach. Analysis by NMR spectroscopy of its alditol 12 and 
comparison with the data described for the natural product11 confirmed the structure of the 
oligosaccharide present in the T. cruzi mucins. Benzyl glycoside 11 has three external Galp 
plausible of being sialylated, however, studies on the behavior on sialylation using the TcTS 
enzyme showed only two monosialylated products whose relative abundance changed with time. 
Enzymatic synthesis and spectroscopical analysis of S-8 unequivocally established the sialylation 
site of the hexasaccharide 8 at the less hindered (1→3)-linked galactopyranose.  
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Further studies to determine which Galp is sialylated first in 11 could contribute to 
understand if a modulation in sialylation is operating through mucin oligosaccharides. Also, the 
Galf containing hexasaccharides could be useful for the characterization of the unknown glycosyl 
transferases involved in the construction of the T. cruzi mucins. 
 
4. Experimental 
4.1. General 
TLC was performed on 0.2 mm silica gel 60 F254 aluminium supported plates. Detection 
was effected by exposure to UV light or by spraying with 10% (v/v) H2SO4 in EtOH and charring. 
Column chromatography was performed on silica gel 60 (230–400 mesh). NMR spectra were 
recorded with a Bruker AVANCE II 500 spectrometer at 500 MHz (1H) and 125.8 MHz(13C). 
Chemical shifts are given relative to the signal of internal acetone standard at δ 2.22 and 30.89 
ppm for 1H NMR and 13C NMR spectra, respectively, when recorded in D2O. 1H and 13C 
assignments were supported by 2D COSY, TOCSY, NOESY and HSQC experiments. High 
resolution mass spectra (HRMS) were recorded on a BRUKER micrOTOF-Q II spectrometer. 
For the sialylation experiments a recombinant TcTS expressed in Escherichia coli was 
kindly provided by the group of A. C. C. Frasch from Universidad Nacional General San Martin 
(Buenos Aires, Argentina). Sialyllactose was obtained from bovine colostrum by an adaptation of 
a reported method.38 Analysis by HPAEC-PAD was performed using a Dionex ICS 3000 HPLC 
system equipped with a pulse amperometric detector. The following programs were used: 
Condition 1, a CarboPac PA-100 ion exchange analytical column (4 ×250 mm) equipped with a 
guard column PA-100 (4 × 50 mm) and 60 mM NaAcO in 100 mM NaOH at a flow rate of 1.0 
mL/min and 25 °C; Condition 2, a CarboPac PA-20 ion exchange analytical column (3 ×150 mm) 
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equipped with a guard column PA-20 (3 × 30 mm) and a lineal gradient over 30 min from 20 to 
200 mM NaAcO in 100 mM NaOH at a flow rate of 0.5 mL/min and 25 °C; Condition 3, a 
CarboPac PA-100 ion exchange analytical column (4 ×250 mm) equipped with a guard column 
PA-100 (4 × 50 mm) and a lineal gradient over 60 min from 50 to 300 mM NaAcO in 100 mM 
NaOH at a flow rate of 0.9 mL/min and 25 °C 
 
4.2. Synthesis 
 
4.2.1. Benzyl (2,3,4,6-tetra-O-acetyl-β-D-galactopyranosyl)-(1→2)-[2,3,4,6-tetra-O-acetyl-β-
D-galactopyranosyl-(1→3)]-4,6-di-O-acetyl-β-D-galactopyranosyl-(1→6)-[2,3,4,6-tetra-O-
acetyl-β-D-galactopyranosyl-(1→2)-3,5,6-tri-O-benzoyl-β-D-galactofuranosyl-(1→4)]-2-
acetamido-3-O-benzoyl-2-deoxy-α-D-glucopyranoside (15) 
To a flask containing recently purified and dried benzyl 2,3,4,6-tetra-O-acetyl-β-D-
galactopyranosyl-(1→2)-3,5,6-tri-O-benzoyl-β-D-galactofuranosyl-(1→4)-2-acetamido-3-O-
benzoyl-2-deoxy-α-D-glucopyranoside27 (14, 114 mg, 0.093 mmol), and activated 4Å powdered 
molecular sieves, a solution of O-[2,3-di-O-(2,3,4,6-tetra-O-acetyl-β-D-galactopyranosyl)-4,6-di-
O-acetyl-α-D-galactopyranosyl] trichloroacetimidate26 (13, 122 mg, 0.114 mmol, 1.2 equiv) in 
freshly distilled anhydrous CH3CN (5 mL) was added, and the suspension was cooled to −20 °C 
under an argon atmosphere. After 15 min of vigorous stirring, TMSOTf  (7 µL, 0.039 mmol, 0.4 
equiv) was added and the stirring continued for 24 h at −18 °C and then for additional 26 h more 
at 5 °C. After cooling the mixture to 0 ºC, the reaction was stopped by the addition of Et3N (5.5 
µL, 0.41 equiv), filtered and the molecular sieves were washed with CH3CN (2 x 3 mL). The 
filtrate was concentrated under reduced pressure at room temperature and the residue was purified 
by column chromatography (10:17 hexane-EtOAc). 
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The first fraction gave unreacted acceptor 14 (71 mg, 62%). The next fraction afforded 65 
mg of hexasaccharide derivative 15 (33%) as a foamy solid: Rf 0.25 (1:1.7 hexane-EtOAc, double 
development), [α]D +1.9º (c 1, CHCl3); 1H NMR (CDCl3, 500 MHz): δ  8.04 – 7.24 (m, 25H, 
arom.), 6.20 (d, 1H, J = 9.6 Hz, NH), 5.62 (dd, 1H, J = 10.6, 9.4 Hz, H-3 GlcNAc), 5.51 (bs, 1H, 
H-1 Galf), 5.40–5.33 (m, 6H, H-5 Galf, H-3 Galf, 4 H-4 of 4 Galp units), 5.22 (dd, 1H, J = 10.3, 
8.0 Hz, H-2 Galp β(1→3)†), 5.15 (dd, 1H, J = 10.6, 3.4 Hz, H-3 Galp β(1→2)-Galp †), 5.12 (dd, 
1H, J = 10.3, 8.1 Hz, H-2 Galp-β(1→2)-Galf †), 5.08 (dd, 1H, J = 10.6, 7.6 Hz, H-2 Galp-β(1→2)-
Galp†), 5.02 (dd, 1H, J = 10.3, 3.5 Hz, H-3 Galp-β(1→3)†), 5.01 (d, 1H, J = 8.0 Hz, H-1 Galp-
β(1→3)†), 4.99 (dd, 1H, J = 10.3, 3.4 Hz, H-3 Galp-β(1→2)-Galf †), 4.98 (d, 1H, J = 3.4 Hz, H-1 
GlcNAc), 4.94 (d, 1H, J = 8.1 Hz, H-1 Galp-β(1→2)-Galf †), 4.87 (d, 1H, J = 7.6 Hz, H-1 Galp-
β(1→2)-Galp †); 4.84, 4.56 (2d, 2H, J = 11.7 Hz, CH2Ph), 4.66 (d, 1H, J = 7.6 Hz, H-1 Galp-
β(1→6)), 4.48–4.42 (m, 3H, H-2 GlcNAc, H-4 Galf, H-6a Galf), 4.36–4.23 (m, 5H), 4.22 (bs, 1H, 
H-2 Galf), 4.20–4.09 (m, 3H), 4.08 (dd, 1H, J = 9.1, 3.8 Hz, H-3 Galp-β(1→6)), 4.05–3.96 (m, 
6H), 3.91 (dd, 1H, J = 9.1, 7.6 Hz, H-2 Galp-β(1→6)), 3.91–3.79 (m, 3H), 2.19, 2.16, 2.09, 2.07 
(4s, 12H, CH3CO); 2.04, 2.03 (2s, 9H, CH3CO); 2.02, 2.01, 1.99 (3s, 9H, CH3CO), 1.97 (s, 6H, 
CH3CO), 1.95, 1.92 (2s, 6H, CH3CO), 1.80 (s, 6H, CH3CO). †The assignments could be 
interchanged; 13C NMR (CDCl3, 125.8 MHz): δ 170.4, 170.3 x 2, 170.2, 170.1 x 2, 170.0, 169.9, 
169.8, 169.6, 169.5, 168.9 (CH3CO); 167.0 (CH3CONH); 165.8, 165.5, 165.2 (PhCO); 136.7–
128.3 (C-aromatics); 105.9 (C-1 Galf), 102.3 (C-1 Galp-β(1→6)), 100.0, 99.9, 99.3 (C-1 Galp-
β(1→2)-Galp, C-1 Galp-β(1→2)-Galf, C-1 Galp-β(1→3)), 96.2 (C-1 GlcNAc), 87.0 (C-2 Galf), 
80.0 (C-4 Galf), 79.0 (C-2 Galp-β(1→6)), 76.8 (C-3 Galf), 75.7 (C-4 GlcNAc), 75.3 (C-3 Galp-
β(1→6)); 71.8, 71.2, 70.8, 70.7, 70.6 x 2, 70.5, 70.2, 70.1; 69.9 and 69.8 (C-2 Galp-β(1→2), C-2 
Galp-β(1→3), CH2Ph), 69.4 (C-6 GlcNAc), 68.7, 68.2, 66.9 x 2, 66.8; 62.7 (C-6 Galf); 61.8, 60.6 
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x 2, 60.2 (4 C-6 of 4 Galp units), 52.2 (C-2 GlcNAc), 22.9 (CH3CONH); 20.9 x 2, 20.7, 20.6 x 4, 
20.5 x 4, 20.4 (CH3CO); HRMS (ESI) m/z calcd for C101H115NNaO49 [M+Na]+: 2148.6436. 
Found: 2148.6451. 
 
4.2.2. Benzyl β-D-galactopyranosyl-(1→2)-[β-D-galactopyranosyl-(1→3)]-β-D-
galactopyranosyl-(1→6)-[β-D-galactopyranosyl-(1→2)-β-D-galactofuranosyl-(1→4)]-2-
acetamido-2-deoxy-α-D-glucopyranoside (11)  
To a cooled (0 ºC) solution of 15 (31 mg, 0.015 mmol) in anhydrous methanol (1 mL), was 
added a solution 2.6 M NaOCH3-CH3OH (200 µL) and the mixture was stirred for 1h at 0 °C 
followed by 2 h at rt. The solution was purified by cationic exchange chromatography column 
(Amberlite IR-120 plus resin 200 mesh, H+ form) eluting with 9:1 CH3OH-H2O. The eluate was 
concentrated under reduced pressure and the methyl benzoate was co-evaporated with water (5 x 1 
mL). Further purification through a C8 cartridge, elution with water followed by concentration at 
30 ºC gave 16 mg of 11 (98%), as an amorphous white solid: Rf 0.35 (7:1:1 n-propanol-EtOH-
H2O); [α]D +29.7º (c 1,H2O); 1H NMR (D2O, 500 MHz): δ 7.48 – 7.38 (m, 5H, aromatics), 5.54 
(d, 1H, J = 2.0 Hz, H-1B), 4.96 (d, 1H, J = 3.5 Hz, H-1A), 4.83 (d, 1H, J = 7.7 Hz, H-1E); 4.74, 
4.57 (2d, 2H, J = 12.2 Hz, CH2Ph), 4.67 (d, 1H, J = 7.4 Hz, H-1F), 4.64 (d, 1H, J = 7.9 Hz, H-1D), 
4.60 (d, 1H, J = 7.9 Hz, H-1C), 4.38 (dd, 1H, J = 4.3, 2.0 Hz, H-2B), 4.26 (dd, 1H, J = 7.4, 4.3 Hz, 
H-3B), 4.20 (d, 1H, J = 3.2 Hz, H-4D), 4.13 (dd, 1H, J = 10.0, 1.0 Hz, H-6aA), 4.10 (dd, 1H, J = 
7.5, 3.5 Hz, H-4B), 4.02–3.57 (m, 31H), 1.96 (s, 3H, CH3CONH); 13C NMR(D2O, 125.8 MHz): δ 
174.9 (CH3CONH); 137.6-128.9 (C-aromatics), 107.5 (C-1B), 104.7 (C-1F), 103.4 (C-1E); 102.4, 
102.3 (C-1D and C-1C), 96.6 (C-1A), 87.6 (C-2B), 83.7 (C-3D), 82.9 (C-4B), 78.6 (C-4A), 76.1 (C-
2D); 76.0, 75.9, 75.7 x 2, 75.1, 73.6, 73.4, 73.2, 72.1, 71.8, 71.5, 70.9, 70.7 (CH2Ph); 70.3, 69.9, 
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69.8, 69.5; 69.3 (C-4D), 69.1; 68.4 (C-6A), 63.3 (C-6B); 62.0, 61.8, 61.6, 61.4 (C-6D, C-6E, C-6F, 
C-6C), 54.3 (C-2A), 22.4 (CH3CONH). HRMS (ESI) m/z calcd for C45H71NNaO31 [M+Na]+: 
1144.3908. Found: 1144.3890. 
 
4.2.3. β-D-Galactopyranosyl-(1→2)-[β-D-galactopyranosyl-(1→3)]-β-D-galactopyranosyl-
(1→6)-[β-D-galactopyranosyl-(1→2)-β-D-galactofuranosyl-(1→4)]-2-acetamido-2-deoxy-α,β-
D-glucopyranose (10)  
To a solution of 11 (15 mg, 0.013 mmol) in 9:1 CH3OH-H2O (2 mL), 10% Pd(C) (16 mg) 
were added and the suspension was hydrogenated for 22 h at 40 psi (3 atm) at rt when a tlc 
showed no11 left. The catalyst was filtered and the filtrate was concentrated at 25 ºC, affording 10 
(13 mg, 94 %) as a hygroscopic amorphous solid: Rf 0. 21 (7:2:2 n-Propanol–EtOH–H2O), [α]D 
+0.5º (c 1,H2O);1H NMR (D2O, 500 MHz): δ anomeric region and diagnostic signals: 5.55 (m, 
1H, H-1 Galf α and β anomers), 5.21 (d, 0.75H, J = 3.4 Hz; H-1 α-GlcNAc), 4.83 (d; 0.25H, J = 
7.7 Hz; H-1 β-GlcNAc ), 4.73 – 4.58 (m; 4H; 4 H-1 Galp α anomer; 4 H-1 Galp β anomer); 4.40 
(dd; 0.75H; J = 4.1, 1.9 Hz; H-2 Galf α anomer), 4.38 (dd; 0.25H; J = 3.9, 1.7 Hz; H-2 Galf 
β anomer), 2.05 (s; 3H; CH3CONH). 13C NMR (D2O, 50.3 MHz): δ anomeric region and 
diagnostic signals: 175.6, 175.3 (CH3CONH α and β anomers), 107.6 (C-1 Galf α anomer), 107.5 
C-1 Galf β anomer);104.7, 103.6, 102.4, 102.3 (4 C-1 Galp); 95.9 (C-1 β-GlcNAc), 91.4 (C-1 α-
GlcNAc), 57.5 (C-2 β-GlcNAc), 54.9 (C-2 α-GlcNAc), 23.0, 22.7 (CH3CONH α and β anomers). 
HRMS (ESI) m/z calcd for C38H65NNaO31 [M+Na]+: 1054.3433. Found: 1054.3455. 
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4.2.4. β-D-Galactopyranosyl-(1→2)-[β-D-galactopyranosyl-(1→3)]-β-D-galactopyranosyl-
(1→6)-[β-D-galactopyranosyl-(1→2)-β-D-galactofuranosyl-(1→4)]-2-acetamido-2-deoxy-D-
glucitol (12) 10 
To a cooled solution (0ºC) of 10 (11 mg, 0.011 mmol) in 9:1 methanol-water (2 mL), 
sodium borohydride (30 mg, 0.79 mmol) was added and the suspension was gently stirred at rt for 
16 h, when TLC analysis showed disappearance of the starting compound. The solution was 
decationized by passing through a column of Amberlite IR-120 plus, the resin was washed with 
water and the combined solutions were concentrated to dryness. The residue was co-evaporated 
with methanol (4 x 1 mL), dissolved in deionized water and the solution was filtered through a C8 
cartridge. Evaporation of the filtrate under reduced pressure gave 9 mg of 12 (82 %) as an 
amorphous solid: [α]D -1.1º (c 0.6, H2O); 1H NMR (D2O, 500 MHz): δ 5.53 (bs, 1H, H-1 Galf),  
4.85 (d, 1H, J = 7.8 Hz), 4.66 (d, 1H, J = 7.6 Hz), 4.63 (d, 1H, J = 7.9 Hz, H-1 Galp-β(1→6)), 
4.59 (d, 1H, J = 7.8 Hz), 4.43 (d, 1H, J = 3.1 Hz, H-2 Galf), 4.25 (dd, 1H, J = 3.1, 6.4 Hz, H-3 
Galf), 4.20 (d, 1H, J = 3.0 Hz, H-4 Galp-β(1→6)), 4.19 - 4.12 (m, 3H, H-4 Galf, H-2 GlcNAc, H-
6a GlcNAc), 4.06 (m, 1H, H-5 GlcNAc), 4.01 (dd, 1H, J = 9.7, 3.0 Hz, H-3 Galp-β(1→6)), 3.96 -
3.54 (m, 30H), 2.05 (s, 3H, CH3CONH); 13C NMR (D2O, 125.8 MHz): δ 175.1 (CH3CONH), 
107.8 (C-1 Galf); 104.7, 103.4, 102.4, 102.1; 88.1 (C-2 Galf), 83.9 (C-4 Galf), 83.5 (C-3 Galp-
β(1→6)); 78.1, 76.5 (C-2 Galp-β(1→6)), 76.4 (C-3 Galf); 76.0, 75.9, 75.8, 75.3, 73.5 x 2, 73.2, 
72.2, 71.8, 71.5, 71.3; 71.1 (C-6 GlcNAc); 70.3, 69.7, 69.5, 69.4, 69.2, 69.0; 63.5 (C-6 Galf); 61.8; 
61.7 x 2, 61.5 x 2 (C-1 GlcNAcol, 4 C-6 Galp units); 53.2 (C-2 GlcNAcol); 22.8 (CH3CONH). 
HRMS (ESI) m/z calcd for C38H67NNaO31 [M+Na]+: 1056.3589. Found: 1056.3572. 
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4.2.5. Benzyl 5-N-acetyl-α-D-neuraminyl-(2→3)-β-D-galactopyranosyl-(1→3)-[β-D-
galactopyranosyl-(1→2)]-β-D-galactopyranosyl-(1→6)-[β-D-galactofuranosyl-(1→2)-β-D-
galactofuranosyl-(1→4)]-2-acetamido-2-deoxy-α-D-glucopyranoside (S-8) 
Benzyl β-D-galactopyranosyl-(1→3)-[β-D-galactopyranosyl-(1→2)]-β-D-galactopyranosyl-
(1→6)-[β-D-galactofuranosyl-(1→2)-β-D-galactofuranosyl-(1→4)]-2-acetamido-2-deoxy-α-D-
glucopyranoside28 (8, 6 mg) and 3´-sialyllactose (6.5 mg) were incubated with 0.022 mg of 
recombinant TcTS in 0.5 mL of 20 mM Tris buffer pH 7.4 containing 30 mM NaCl for 14 h at 25 
°C. The synthesis was performed in triplicate and each reaction analyzed by HPAEC. The three 
incubation mixtures were combined and the sialylated compound S-8 was purified by passing 
through an anion exchange resin (AG1X2, acetate form, BioRad, 1.2 x 15 cm). Neutral 
compounds, namely benzyl hexasaccharide 8 and lactose were eluted with H2O and sialylated 
compounds with 200 mM pyridinium acetate buffer pH 5. Fractions (1.5 mL) were collected and 
analyzed by HPAEC. The remaining sialyllactose was eluted with the first 80 mL of 200 mM 
pyridinium acetate buffer. Further elution with the same buffer afforded sialylated compound S-8. 
The pooled fractions were concentrated under vacuum at rt, redissolved in water and lyophilized 
to afford 2.7 mg of S-8 as an amorphous white powder. 1H NMR (D2O, 500 MHz): δ 7.46-7.38 
(m, 5H, aromatics), 5.48 (d, 1H, J = 1.2 Hz, H-1B), 5.24 ( d, 1H, J =1.5 Hz, H-1C), 4.96 (d, 1H, J = 
3.5 Hz, H-1A), 4.85 (d, 1H, J = 7.7 Hz, H-1E); 4.74, 4.57 (2d, 2H, J = 12.0 Hz, CH2Ph), 4.71 (d, 
1H, J = 8.0 Hz, H-1F), 4.54 (d, 1H, J = 7.7 Hz, H-1D), 4.27–4.23 (m, 2H, H-2B, H-3B), 4.20–4.19 
(m, 2 H, H-6aA, H-4D), 4.14 (dd, 1H, J = 1.7, 3.5 Hz, H-2C), 4.12-4.09 (m, 2H, H-3C, H-4D), 4.08 
(dd, 1 H, J = 8.0, 3.2 Hz, H-3F), 4.01 (dd, 1H, J = 6.5, 4.0 Hz, H-4C), 4.03-3.56 (m, 33 H), 2.77 
(dd, 1H, J = 12.4, 4.6 Hz, H-3e Neu5Ac), 2.03 (s, 3 H, CH3CONH Neu5Ac), 1.95 (s, 3 H, 
CH3CONH), 1.81 (t, 1 H, J = 12.1 Hz, H-3a Neu5Ac); 13C NMR  (D2O): δ 175.7, 174.8 
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(CH3CONH), 129.4 (aromatic), 107.2 (C-1B), 106.4 (C-1C), 104.8 (C-1F), 103.6 (C-1E), 102.7 (C-
1D), 96.6 (C-1A), 86.0 (C-2B), 84.2 (C-4C), 83.9 (C-3D), 84.4 (C-4B), 82.4 (C-2C), 78.5 (C-4A), 77.6 
(C-3C), 76.5 (C-3F), 76.3, 76.2, 75.6, 75.5, 75.3, 73.7, 73.5, 72.7, 72.4, 72.3, 71.5, 71.2, 70.8 
(CH2Ph), 70.5, 70.4, 70.0, 69.7, 69.3, 69.1, 69.0, 68.7, 68.3, 63.5, 63.4, 63.4, 62.0, 61.7, 61.6; 54.4 
(C-2A), 52.4 (C-5 Neu5Ac), 40.4 (C-3 Neu5Ac), 22.8 (CH3CONH, Neu5Ac), 22.4 (CH3CONH). 
HRMS (ESI) Calcd for C56H88N2NaO39 [M+Na]+: 1435.4856, found: 1435.4804. 
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Legends to figures 
 
Figure 3- Analysis of sialylation of benzyl hexasaccharide 11 with time. Compound 11 (1 mM) 
was incubated with SL (2 mM) and TcTS for 15, 30, 60, 90 and 120 min at room temperature. The 
incubation mixtures were analyzed by HPAEC under condition 3. SL, sialyllactose; SA, sialic 
acid, S-11a and S-11b, monosialylated compound 11; S2-11, disialylated compound 11. 
 
Figure 4- Sialic acid transfer by TcTS to the benzyl hexasaccharide 8. Compound 8 (1 mM) was 
incubated with SL (1 mM) in the absence (A) or presence (B) of TcTS for 15 min at room 
temperature. The incubation mixtures were analyzed by HPAEC under condition 3. L, lactose; SL, 
sialyllactose; S-8, sialylated compound 8. 
 
Figure 5- 1H-NMR spectrum of sialylated compound 8 (D2O, 500 MHz) 
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